51.5 F
Laguna Hills
Thursday, Mar 28, 2024
-Advertisement-

Masimo Says Q3 Sales Top Estimates

Masimo Corp. (Nasdaq: MASI), an Irvine-based medical device maker, reported preliminary third-quarter product revenue ranged from $274 million to $278 million, topping the $243.7 million average estimate of eight analysts.

Masimo also returned to providing its annual forecast updates, which it declined to do in April and July, citing the uncertainties caused by the coronavirus. It boosted its 2020 product revenue forecast to $1.124 billion to $1.128 billion, up from a January prediction of $1.035 billion. Analysts expected $1.07 billion this year.

The annual forecast implies fourth quarter sales of around $279 million, above the $254 million expected by analysts.

The company will announce its third quarter results on Oct. 27, hosted by Chief Executive and founder Joe Kiani.

In after hours trading, shares were flat at $241. The shares have climbed 62% since mid-March to a $13.2 billion market cap.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Peter J. Brennan
Peter J. Brennan
Peter J. Brennan has been a journalist for 40 years. He spent a decade in Latin America covering wars, narcotic traffickers, earthquakes, and business. His resume includes 15 years at Bloomberg News where his headlines and articles sometimes moved the market caps of companies he covered by hundreds of millions of dollars. His articles have been published worldwide, including the New York Times and the Washington Post; he's appeared on CNN, CBC, BBC, and Bloomberg TV. He was awarded a Kiplinger Fellowship at The Ohio State University.
-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-